search
Back to results

Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia (SIP)

Primary Purpose

Sleep Disorder; Insomnia Type, Psychiatric Disorders

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Group-based cognitive behavioral therapy for insomnia
Group-based cognitive behavioral therapy for insomnia and additive bb-glasses
8-week wait list for sleep-school
Sponsored by
Haukeland University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Disorder; Insomnia Type focused on measuring sleep disorders, insomnia, psychiatric disorders, bb-glasses, group-based cognitive behavioural therapy for insomnia

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients referred to the sleep-school at Bjørgvin DPS psychiatric hospital
  • Patients fulfilling the Diagnostic Manual for Mental Disorders (DSM-V) criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the International Statistical Classification of Diseases and Related Health Problems (ICD-11) diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)

Exclusion Criteria:

  • Nightwork
  • Patients that do not fulfil the DSM-V criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the ICD-10 diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)

Sites / Locations

  • Haukeland University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

n=15, Sleep-school 8 weeks

n=15, Sleep-school 8 weeks and additive bb-glasses

n=30 8-week wait list for sleep-school

Arm Description

Patients receive treatment as usual in the psychiatric clinic combined with participation in the sleep school. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.

Patients receive treatment as usual in the psychiatric clinic combined with participation in the sleep school and additive treatment with bb-glasses. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.

Patients receive treatment as usual in the psychiatric clinic while they wait for participation in the sleep school. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.

Outcomes

Primary Outcome Measures

Changes in anxiety and depression
Measured by the Hospital anxiety and depression scale (HADS), Becks Depression Inventory -II (BDI-II) and Becks Anxiety Inventory (BAI).
Insomnia symptoms
Measured by the questionnaires Insomnia severity Index (ISI) and Bergen Insomnia Scale (BIS). From sleep diaries; SOL, WASO and SE.

Secondary Outcome Measures

Changes in insomnia diagnosis
Measured by the Bergen Bergen Insomnia Scale (BIS). The BIS measure subjective symptoms of insomnia during the previous week and give a total score (minimum 0, maximum 42; the higher the score, the worse severity of insomnia) and a clinical incidence of insomnia diagnosis-score (yes/no)
Changes in insomnia severity
Measured by the Insomnia Severity Index (ISI). The ISI is a 7-item scale assessing the perceived severity of insomnia symptoms (initial, middle, terminal), the degree of satisfaction with sleep, interference with daytime functioning, noticeability of impairment, and concern caused by the sleep problems. The scale is Likert-type with 5 anchor points ranging from 0 to 4. The scale ranges from 0 to 28 and the higher the score, the more severe insomnia. The usual time frame for responding is the last 2 weeks.
Changes in Time in bed (TIB)
Measured by sleep diary; time from bed-time to rise time
Changes in objective early morning awakening (EMA)
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of average minutes early morning awakening.
Changes in objective wake after sleep onset (WASO)
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of average minutes awake after sleep onset.
Changes in Early morning awakening (EMA)
Measured by sleep diary; minutes awake before rise time
Changes in objective time in bed (TIB)
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number in minutes of average time in bed.
Changes in objective sleep efficiency (SE)
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number from 0-100% that gives average sleep efficiency.
Changes in objective total sleep length/time asleep (TST),
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number in minutes of average total sleep time.
Changes in Sleep onset latency (SOL)
Measured by sleep diary; time in minutes from bed-time to estimated sleep onset
Changes in Total sleep length/time asleep (TST)
Measured by sleep diary: Time in bed minus time awake
Changes in Wake after sleep onset (WASO)
Measured by sleep diary; minutes awake after sleep onset
Changes in Sleep quality (SQ)
Measured by sleep diary; subjective assesment of sleep quality on a scale from 1=very light to 5=very deep
Changes in Daytime function (DF)
Measured by sleep diary; subjective assesment of daytime function on a scale from 1=very good to 5=very poor
Changes in Sleep efficiency (SE)
Measured by sleep diary; total sleep time/time in bed x 100= percentage SE
Changes in objective sleep onset latency (SOL)
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of minutes of average sleep onset latency.
Changes in beliefs about sleep
Measured by Dysfunctional Beliefs About Sleep (DBAS-16). The DBAS-16 measures the degree of dysfunctional beliefs about sleep with 16 items. It has 4 subscales (1) sleep-related worry and helplessness; 2) beliefs about sleep medications; 3) expectations about sleep need; and 4) beliefs about the consequences/effects of insomnia and 1 total scale score. The higher the score, the more dysfunctional beliefs about sleep.
Client Satisfaction
Measured by the Client Satisfaction Questionnaire (CSQ8). The CSQ-8 is an 8-item questionnaire that measures patient satisfaction with health services, where the items are rated from 1 (very low satisfaction) to 4 (very high satisfaction). The total score ranges from 8 to 32, with higher scores indicating higher degrees of satisfaction.
Changes in blood pressure
We will measure systolic and diastolic pressure by a digital blood pressure measurement machine.
Suicide attempts and admittances in psychiatric wards
Whether or not suicide has been attempted, if applicable number og attempts and whether or nor the patient has been admitted to a psychitaric ward (voluntary/forced)
Changes in immediate sleepiness
Measured by the Karolinska Sleepiness Scale (KSS). The KSS measure subjective sleepiness at a specific time point (noon). The scale gives a number from 1-9 where 9 indicates "trouble staying awake" and is the worst outcome.
Changes in sleepiness
Measured by the Epworth Sleepiness Scale (ESS). The ESS is an 8-item scale where the respondent grades the likelihood of falling asleep or dozing off in different daily situations. The responses are graded on a 4-point likert scale 0=no likelihodd to 3=very likely. A score of 11 or higher is considered an indication of excessive daytime sleepiness.
Changes in Heart rate variability (HRV)
24 -hour HRV.
Work status
Status of employment/unemployment, percentage disability benefits received

Full Information

First Posted
April 6, 2020
Last Updated
August 21, 2023
Sponsor
Haukeland University Hospital
Collaborators
University of Bergen
search

1. Study Identification

Unique Protocol Identification Number
NCT04463498
Brief Title
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
Acronym
SIP
Official Title
Sleep in Psychiatric Care: A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 17, 2021 (Actual)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
December 31, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Haukeland University Hospital
Collaborators
University of Bergen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Sleep disorders commonly co-occur with psychiatric disorders. Sleep disorders are often treated with medication or not at all in psychiatric care, although there exist a plethora of documentation of the effectiveness of sleep interventions. There is also an increase in studies showing effectiveness of sleep-interventions when the sleep disorder co-occurs with psychiatric illness. The most common and best documented treatment for insomnia is cognitive behavioral therapy for insomnia (CBTi). There is a great gap in the knowledge on how sleep disorders can be treated effectively in psychiatric care. In this project the investigators therefore seek to investigate the effect of non-pharmacological, group-based treatment in a randomized controlled trial (RCT) where sleep and psychiatric symptoms are the primary outcome measures. CBTi comprise of sleep education, sleep restriction, stimulus control and cognitive restructuring of dysfunctional thoughts about sleep.
Detailed Description
The recommended treatment for insomnia is CBTi. Recent research has proven that dark therapy, or blocking light in wavelengths <530 nm by the use of for example orange blue-blocking glasses (bb-glasses), has shown the ability to maintain melatonin production comparable to darkness and to have an additive effect in the treatment of insomnia. The investigators therefore also want to test bb-glasses as an additive treatment to CBTi for insomnia. The sleep-school at Bjørgvin District Psychiatric Hospital (DPS) is an already established treatment since 2017. The insomnia-group gets together every other Monday from noon until 2 pm. The group is open, which means that participants start at different dates and meet people in the group that might be at the end of their CBTi treatment. Participants are patients at the general psychiatric outpatient clinic at Bjørgvin DPS. Participant have been referred to the sleep-team by their psychologist or doctor. In this RCT the investigators will carry on the same structure for the group for participants that are recruited to the RCT. All participants have an individual consultation before joining the group where the focus is on eligibility to participate in the group-based treatment, diagnostic evaluation, receive a standardized education on sleep-regulation and sleep hygiene advice and receive a date to start the group-based CBTi treatment. In a randomized manner, they will be allocated to the sleep-school group and start the treatment on the next possible date or to a 8 week wait-list and receive a date the treatment starts. All eligible participants will be informed that there may be a waitlist and receive a start-date without being informed that thay are in a waitlist group or not a waitlist group. All participants will be treated as usual (TAU) for their psychiatric problems parallel to either sleep-school or waitlist. Participants that start sleep-school as soon as possible, are also allocated to a) ordinary group-based CBTi 8 weeks or b) group-based CBTi 8 weeks and bb-glasses. All participant will be followed up after 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disorder; Insomnia Type, Psychiatric Disorders
Keywords
sleep disorders, insomnia, psychiatric disorders, bb-glasses, group-based cognitive behavioural therapy for insomnia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
Participant
Masking Description
All eligible participants will be informed that there may be a waitlist (length not specified) and receive a start-date without being informed that thay are in a waitlist group or not a waitlist group.
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
n=15, Sleep-school 8 weeks
Arm Type
Experimental
Arm Description
Patients receive treatment as usual in the psychiatric clinic combined with participation in the sleep school. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.
Arm Title
n=15, Sleep-school 8 weeks and additive bb-glasses
Arm Type
Experimental
Arm Description
Patients receive treatment as usual in the psychiatric clinic combined with participation in the sleep school and additive treatment with bb-glasses. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.
Arm Title
n=30 8-week wait list for sleep-school
Arm Type
Active Comparator
Arm Description
Patients receive treatment as usual in the psychiatric clinic while they wait for participation in the sleep school. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.
Intervention Type
Behavioral
Intervention Name(s)
Group-based cognitive behavioral therapy for insomnia
Other Intervention Name(s)
Group - CBTi
Intervention Description
Sleep education, sleep restriction, stimulus control, cognitive restructuring, relaxation techniques
Intervention Type
Behavioral
Intervention Name(s)
Group-based cognitive behavioral therapy for insomnia and additive bb-glasses
Other Intervention Name(s)
Group - CBTi & bb-glasses
Intervention Description
Sleep education, sleep restriction, stimulus control, cognitive restructuring, relaxation techniques, bb-glasses worn from 3 hrs before bedtime.
Intervention Type
Other
Intervention Name(s)
8-week wait list for sleep-school
Other Intervention Name(s)
Treatment as usual
Intervention Description
Treatment as usual in a psychiatric outpatient clinic
Primary Outcome Measure Information:
Title
Changes in anxiety and depression
Description
Measured by the Hospital anxiety and depression scale (HADS), Becks Depression Inventory -II (BDI-II) and Becks Anxiety Inventory (BAI).
Time Frame
baseline, bi-weekly assesment (HADS) and post intervention after 8 weeks, follow-up after 12 months
Title
Insomnia symptoms
Description
Measured by the questionnaires Insomnia severity Index (ISI) and Bergen Insomnia Scale (BIS). From sleep diaries; SOL, WASO and SE.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Secondary Outcome Measure Information:
Title
Changes in insomnia diagnosis
Description
Measured by the Bergen Bergen Insomnia Scale (BIS). The BIS measure subjective symptoms of insomnia during the previous week and give a total score (minimum 0, maximum 42; the higher the score, the worse severity of insomnia) and a clinical incidence of insomnia diagnosis-score (yes/no)
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in insomnia severity
Description
Measured by the Insomnia Severity Index (ISI). The ISI is a 7-item scale assessing the perceived severity of insomnia symptoms (initial, middle, terminal), the degree of satisfaction with sleep, interference with daytime functioning, noticeability of impairment, and concern caused by the sleep problems. The scale is Likert-type with 5 anchor points ranging from 0 to 4. The scale ranges from 0 to 28 and the higher the score, the more severe insomnia. The usual time frame for responding is the last 2 weeks.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Time in bed (TIB)
Description
Measured by sleep diary; time from bed-time to rise time
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in objective early morning awakening (EMA)
Description
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of average minutes early morning awakening.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in objective wake after sleep onset (WASO)
Description
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of average minutes awake after sleep onset.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Early morning awakening (EMA)
Description
Measured by sleep diary; minutes awake before rise time
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in objective time in bed (TIB)
Description
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number in minutes of average time in bed.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in objective sleep efficiency (SE)
Description
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number from 0-100% that gives average sleep efficiency.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in objective total sleep length/time asleep (TST),
Description
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number in minutes of average total sleep time.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Sleep onset latency (SOL)
Description
Measured by sleep diary; time in minutes from bed-time to estimated sleep onset
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Total sleep length/time asleep (TST)
Description
Measured by sleep diary: Time in bed minus time awake
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Wake after sleep onset (WASO)
Description
Measured by sleep diary; minutes awake after sleep onset
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Sleep quality (SQ)
Description
Measured by sleep diary; subjective assesment of sleep quality on a scale from 1=very light to 5=very deep
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Daytime function (DF)
Description
Measured by sleep diary; subjective assesment of daytime function on a scale from 1=very good to 5=very poor
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Sleep efficiency (SE)
Description
Measured by sleep diary; total sleep time/time in bed x 100= percentage SE
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in objective sleep onset latency (SOL)
Description
Measured by Actiwatch (AW) Spectrum PLUSS. The activity recorder is worn on the wrist for 7 consecutive days. The data is downloaded to a computer program that gives the data; a number of minutes of average sleep onset latency.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in beliefs about sleep
Description
Measured by Dysfunctional Beliefs About Sleep (DBAS-16). The DBAS-16 measures the degree of dysfunctional beliefs about sleep with 16 items. It has 4 subscales (1) sleep-related worry and helplessness; 2) beliefs about sleep medications; 3) expectations about sleep need; and 4) beliefs about the consequences/effects of insomnia and 1 total scale score. The higher the score, the more dysfunctional beliefs about sleep.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Client Satisfaction
Description
Measured by the Client Satisfaction Questionnaire (CSQ8). The CSQ-8 is an 8-item questionnaire that measures patient satisfaction with health services, where the items are rated from 1 (very low satisfaction) to 4 (very high satisfaction). The total score ranges from 8 to 32, with higher scores indicating higher degrees of satisfaction.
Time Frame
post intervention after 8 weeks
Title
Changes in blood pressure
Description
We will measure systolic and diastolic pressure by a digital blood pressure measurement machine.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Suicide attempts and admittances in psychiatric wards
Description
Whether or not suicide has been attempted, if applicable number og attempts and whether or nor the patient has been admitted to a psychitaric ward (voluntary/forced)
Time Frame
baseline and post intervention after 8 weeks, and at follow-up after 12 months
Title
Changes in immediate sleepiness
Description
Measured by the Karolinska Sleepiness Scale (KSS). The KSS measure subjective sleepiness at a specific time point (noon). The scale gives a number from 1-9 where 9 indicates "trouble staying awake" and is the worst outcome.
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in sleepiness
Description
Measured by the Epworth Sleepiness Scale (ESS). The ESS is an 8-item scale where the respondent grades the likelihood of falling asleep or dozing off in different daily situations. The responses are graded on a 4-point likert scale 0=no likelihodd to 3=very likely. A score of 11 or higher is considered an indication of excessive daytime sleepiness.
Time Frame
baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in Heart rate variability (HRV)
Description
24 -hour HRV.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Work status
Description
Status of employment/unemployment, percentage disability benefits received
Time Frame
baseline and post intervention after 8 weeks, and at follow-up after 12 months
Other Pre-specified Outcome Measures:
Title
Changes in degree of experienced pain
Description
Measured by a visual analogue scale (VAS Pain) ranging from 0 to 10. The higher the score, the worse the pain.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in self reported emotion regulation ability
Description
Measured by Difficulties in Emotion Regulation Scale (DERS) which is a 18-item self-report measure of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never [0-10%]") to 5 ("almost always [91-100%]"). Higher scores suggest greater problems with emotion regulation.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in vigilance
Description
Measured by the Conners Continuous Performance (CPT) Test 3rd Edition™ (Conners CPT 3™)
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in symptoms of inattention
Description
Measured by the Adult attention deficit hyperactivity disorder (ADHD) Self-Rating Scale (ASRS). The scale contains the 18 symptoms of inattention, hyperactivity, and impulsivity defining ADHD according to the DSM-IV-TR and DSM-5. The severity of the symptoms are reported on a 5-point Likert-type scale (0-4 = never, rarely, sometimes, often, to very often), with a total range of 0-72. The higher the score, the more symptoms of inattention.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months
Title
Changes in symptoms of hypochondria
Description
Measured by the The Whiteley Index (WI). The 14-item WI measures assess health anxiety on a likert-scale from 1="not at all" to "5=very much". The higher the score, the more severe health anxiety.
Time Frame
baseline and post intervention after 8 weeks, follow-up after 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients referred to the sleep-school at Bjørgvin DPS psychiatric hospital Patients fulfilling the Diagnostic Manual for Mental Disorders (DSM-V) criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the International Statistical Classification of Diseases and Related Health Problems (ICD-11) diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school) Exclusion Criteria: Nightwork Patients that do not fulfil the DSM-V criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the ICD-10 diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ane Wilhelmsen-Langeland, PhD
Phone
+47 55957000
Email
ane.wilhelmsen-langeland@helse-bergen.no
First Name & Middle Initial & Last Name or Official Title & Degree
Berge Osnes, PhD
Phone
+47 55957000
Email
berge.osnes@helse-bergen.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ane Wilhelmsen-Langeland, PhD
Organizational Affiliation
Haukeland University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haukeland University Hospital
City
Bergen
ZIP/Postal Code
5113
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ane Wilhelmsen-Langeland, PhD
Phone
+47 92843253
Email
ane.wilhelmsen-langeland@helse-bergen.no
First Name & Middle Initial & Last Name & Degree
Berge Osnes, PhD
Phone
+47 92445081
Email
berge.osnes@helse-bergen.no

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The investigators plan to share the following individual participant data (IPD); Study protocol and Informed Consent Form (ICF) IPD Sharing Time Frame Definition: A description of when the IPD and any additional supporting information will become available and for how long, including the start and end dates or period of availability. This may be provided as an absolute date (for example, starting in January 2025) or as a date relative to the time when summary data are published or otherwise made available (for example, starting 6 months after publication). Limit: 1000 characters. IPD Sharing Access Criteria Definition: Describe by what access criteria IPD and any additional supporting information will be shared, including with whom, for what types of analyses, and by what mechanism. Information about who will review requests and criteria for reviewing requests may also be provided.
IPD Sharing Time Frame
By August 31st 2025
IPD Sharing Access Criteria
Not yet decided. PI will be reviewing requests.

Learn more about this trial

Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia

We'll reach out to this number within 24 hrs